January 2019

December 2018

November 2018

July 2018

January 2018

October 2017

Extended partnership between Radiomedix Inc and ITM´s subsidiary ITG for exclusive distribution of n.c.a Lutetium-177 in North America

2017-10-23T16:25:12+00:00 October 10th, 2017|Press Release, Products, Recent News|

RadioMedix INC, a biotechnological company, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer, and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced they have signed an exclusive [...]

June 2017

RadioMedix Inc. and AREVA Med Announce Completion of the Exploratory Clinical Trial of 203Pb-AR-RMX in patients expressing somatostatin receptor positive neuroendocrine tumors

2017-06-21T16:43:09+00:00 June 21st, 2017|Press Release, Recent News|

Houston, TX; Plano, TX, (June 21st, 2017) - RadioMedix Inc and AREVA Med announced today the completion of the exploratory clinical trial  evaluating the biodistribution and safety of 203Pb-AR-RMX in patients with somatostatin receptor positive [...]

RadioMedix, Inc., received an exclusive distributions rights for SEDECAL Preclinical PET-CT and PET-MR systems in North America.

2017-10-25T16:02:37+00:00 June 19th, 2017|Press Release|

Wednesday, June 7, 2017 RadioMedix, Inc., (Houston, TX) announced today that it has reached an exclusive distribution agreement with Pre-clinical Division of SEDECAL (Madrid, Spain). Under this agreement RadioMedix will distribute the new SEDECAL Preclinical [...]

Load More Posts